scispace - formally typeset
Search or ask a question
Topic

Mass screening

About: Mass screening is a research topic. Over the lifetime, 34508 publications have been published within this topic receiving 1365148 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: VIA screening, in the presence of good training and sustained quality assurance, is an effective method to prevent cervical cancer in developing countries.

511 citations

Journal ArticleDOI
TL;DR: 'At-risk' patients had more complications, higher mortality and longer lengths of stay than 'not at- risk' patients and these variables were significantly related to components of NRS-2002, also when adjusted for confounders.

511 citations

Journal ArticleDOI
TL;DR: Proteinuria was a strong, independent predictor of ESRD in a mass screening setting in Okinawa, Japan, and therefore, asymptomatic proteinuria warrants further work-up and intervention.

507 citations

Journal ArticleDOI
15 Nov 2016-JAMA
TL;DR: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating statin use in adults 76 years and older.
Abstract: Importance Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults. Objective To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in adults. Evidence Review The USPSTF reviewed the evidence on the benefits and harms of screening for and treatment of dyslipidemia in adults 21 years and older; the benefits and harms of statin use in reducing CVD events and mortality in adults without a history of CVD events; whether the benefits of statin use vary by subgroup, clinical characteristics, or dosage; and the benefits of various treatment strategies in adults 40 years and older without a history of CVD events. Conclusions and Recommendations The USPSTF recommends initiating use of low- to moderate-dose statins in adults aged 40 to 75 years without a history of CVD who have 1 or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year CVD event risk of 10% or greater (B recommendation). The USPSTF recommends that clinicians selectively offer low- to moderate-dose statins to adults aged 40 to 75 years without a history of CVD who have 1 or more CVD risk factors and a calculated 10-year CVD event risk of 7.5% to 10% (C recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating statin use in adults 76 years and older (I statement).

506 citations

Journal ArticleDOI
TL;DR: This chapter discusses the management of cervical cancer based on the stage of disease, including attention to palliation and quality of life issues.

506 citations


Network Information
Related Topics (5)
Odds ratio
68.7K papers, 3M citations
90% related
Public health
158.3K papers, 3.9M citations
89% related
Risk factor
91.9K papers, 5.7M citations
89% related
Randomized controlled trial
119.8K papers, 4.8M citations
87% related
Health care
342.1K papers, 7.2M citations
86% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
20223
2021736
2020871
2019821
20181,027
20171,365